Status:
COMPLETED
Contribution of the ENT (Ear, Nose, and Throat) Surgeon's Clinical Evaluation to the Contouring of Target Volumes and Organs Eligible for Radiotherapy in Head and Neck Cancers
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
Radiotherapy, Conformal (IMRT)
Head and Neck Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Radiotherapy (RT), surgery and chemotherapy (CT) are treatments for head and neck cancers, used alone or in combination. Conformal RT with Intensity Modulation (IMRT) is currently the reference techni...
Eligibility Criteria
Inclusion
- Age ≥ 18 years;
- Cancer of the upper aerodigestive tract (oral cavity, oropharynx, larynx, hypopharynx, rhinopharynx, salivary glands, facial sinuses, orbital cavity, ear);
- Cancer confirmed by histopathological analysis;
- Therapeutic protocol including radiotherapy.
Exclusion
- Any history of radiotherapy of the head and neck
- Synchronous head and neck cancer.
Key Trial Info
Start Date :
November 28 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 13 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03265873
Start Date
November 28 2017
End Date
October 13 2023
Last Update
October 26 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital d'Instruction des Armées
Clamart, France, 92140
2
Fondation Ophtalmologique A. de Rothschild
Paris, France, 75019